Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1060-1065

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mooser, V.
Right arrow Articles by Nicod, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mooser, V.
Right arrow Articles by Nicod, P.
Related Collections
Right arrow Pathophysiology
Right arrow CV surgery: coronary artery disease
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1060-1065.)
© 1999 American Heart Association, Inc.


Original Contributions

Effect of Cardiopulmonary Bypass and Heparin on Plasma Levels of Lp(a) and Apo(a) Fragments

Vincent Mooser; Francine Tinguely; Pierre Fontana; Vincent Lenain; Martine Vaglio; Patrick Ruchat; Ludwig K. von Segesser; Santica M. Marcovina; Michèle Markert; Roger Darioli; Pascal Nicod

From the Departments of Internal Medicine (V.M., P.F., V.L., P.N.) and Cardiovascular Surgery (F.T., P.R., L.K.v.S.), the Central Laboratory of Clinical Chemistry (M.V., M.M.), and Medical Policlinic (R.D.), CHUV University Hospital, Lausanne, Switzerland; and the Department of Medicine, Northwest Lipid Research Laboratories, University of Washington, Seattle (S.M.M.).

Correspondence to Vincent Mooser, MD, Department of Internal Medicine, BH 19/135, CH-1011 CHUV Lausanne, Switzerland. E-mail vincent.mooser{at}hola.hospvd.ch

Abstract—Fragments of apolipoprotein(a) [apo(a)], the distinctive glycoprotein of lipoprotein(a) [Lp(a)], are present in human plasma and urine and have been implicated in the development of atherosclerosis. The mechanism responsible for the generation of apo(a) fragments in vivo is poorly understood. In this study, we examined the plasma levels of Lp(a) and apo(a) fragments [or free apo(a)] and urinary apo(a) in 15 subjects who underwent cardiac surgery necessitating cardiopulmonary bypass. We also measured the plasma concentration and activity of polymorphonuclear elastase, an Lp(a)-cleaving enzyme in vitro, and plasma levels of C-reactive protein. Despite a marked activation of polymorphonuclear cells and a pronounced inflammatory response, as documented by an 8-fold and a 35-fold increase in plasma levels of polymorphonuclear elastase and C-reactive protein, respectively, the proportion of plasma free apo(a) to Lp(a) and urinary excretion of apo(a) remained unchanged over a 7-day period after surgery, and polymorphonuclear elastase activity remained undetectable in plasma. No fragmentation of apo(a) was observed ex vivo in plasma samples collected before and after surgery. These data indicate that in this model, apo(a) is not fragmented in plasma and are consistent with the hypothesis that apo(a) fragments result from a constitutively active tissue mechanism that is not modified by cardiac surgery with cardiopulmonary bypass.


Key Words: apolipoprotein(a) • atherosclerosis • elastase • heparin • lipoprotein(a)




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Gonbert, B. Saint-Jore, P. Giral, C. Doucet, J. Chapman, and J. Thillet
Molecular Analysis of Apo(a) Fragmentation in Polygenic Hypercholesterolemia: Characterization of a New Plasma Fragment Pattern
Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1353 - 1358.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. Mooser, M. M. Berger, L. Tappy, C. Cayeux, S. M. Marcovina, R. Darioli, P. Nicod, and R. Chiolero
Major Reduction in Plasma Lp(a) Levels During Sepsis and Burns
Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1137 - 1142.
[Abstract] [Full Text] [PDF]